Cell cycle progression - New therapeutic target for vascular proliferative disease

被引:273
作者
Braun-Dullaeus, RC [1 ]
Mann, MJ [1 ]
Dzau, VJ [1 ]
机构
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
关键词
atherosclerosis; restenosis; bypass; genes; molecular biology;
D O I
10.1161/01.CIR.98.1.82
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Entry into and progression of vascular cells through the cell cycle is considered a key event in vascular proliferative diseases. Multiple growth factors and cytokines have been found to regulate vascular cell proliferation. However, the machinery regulating cell cycle represents the "final common pathway" of these signaling cascades and thus provides an attractive therapeutic target for the prevention of vascular proliferative diseases. This review focuses on the current understanding of the regulation of the cell cycle machinery especially as it relates to vascular cell biology and the feasibility of targeting cell cycle for the prevention of restenosis after balloon angioplasty and bypass vein graft disease.
引用
收藏
页码:82 / 89
页数:8
相关论文
共 115 条
[1]   SUPPRESSION OF NEOINTIMAL SMOOTH-MUSCLE CELL ACCUMULATION IN-VIVO BY ANTISENSE CDC2 AND CDK2 OLIGONUCLEOTIDES IN RAT CAROTID-ARTERY [J].
ABE, J ;
ZHOU, W ;
TAGUCHI, J ;
TAKUWA, N ;
MIKI, K ;
OKAZAKI, H ;
KUROKAWA, K ;
KUMADA, M ;
TAKUWA, Y .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 198 (01) :16-24
[2]   Expression of p53 protein and p53 gene transcripts in rabbit carotid arteries after balloon denudation [J].
Aoyagi, M ;
Yamamoto, M ;
Azuma, H ;
Nagashima, G ;
Niimi, Y ;
Hirakawa, K ;
Yamamoto, K .
HISTOCHEMISTRY AND CELL BIOLOGY, 1997, 107 (05) :365-370
[3]   RAF MEETS RAS - COMPLETING THE FRAMEWORK OF A SIGNAL-TRANSDUCTION PATHWAY [J].
AVRUCH, J ;
ZHANG, XF ;
KYRIAKIS, JM .
TRENDS IN BIOCHEMICAL SCIENCES, 1994, 19 (07) :279-283
[4]   INHIBITORY EFFECTS OF ANTISENSE OLIGODEOXYNUCLEOTIDES TARGETING C-MYC MESSENGER-RNA ON SMOOTH-MUSCLE CELL-PROLIFERATION AND MIGRATION [J].
BIRO, S ;
FU, YM ;
YU, ZX ;
EPSTEIN, SE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (02) :654-658
[5]   C-MYC COOPERATES WITH ACTIVATED RAS TO INDUCE THE CDC2 PROMOTER [J].
BORN, TL ;
FROST, JA ;
SCHONTHAL, A ;
PRENDERGAST, GC ;
FERAMISCO, JR .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (09) :5710-5718
[6]  
BraunDullaeus RC, 1997, FASEB J, V11, P893
[7]   Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: Tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide [J].
Brazelton, TR ;
Morris, RE .
CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (05) :710-720
[8]   EFFECTS OF RAPAMYCIN ON GROWTH FACTOR-STIMULATED VASCULAR SMOOTH-MUSCLE CELL-DNA SYNTHESIS - INHIBITION OF BASIC FIBROBLAST GROWTH-FACTOR AND PLATELET-DERIVED GROWTH-FACTOR ACTION AND ANTAGONISM OF RAPAMYCIN BY FK506 [J].
CAO, W ;
MOHACSI, P ;
SHORTHOUSE, R ;
PRATT, R ;
MORRIS, RE .
TRANSPLANTATION, 1995, 59 (03) :390-395
[9]   ADENOVIRUS-MEDIATED OVER-EXPRESSION OF THE CYCLIN CYCLIN-DEPENDENT KINASE INHIBITOR, P21 INHIBITS VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION AND NEOINTIMA FORMATION IN THE RAT CAROTID-ARTERY MODEL OF BALLOON ANGIOPLASTY [J].
CHANG, MW ;
BARR, E ;
LU, MM ;
BARTON, K ;
LEIDEN, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) :2260-2268
[10]   CYTOSTATIC GENE-THERAPY FOR VASCULAR PROLIFERATIVE DISORDERS WITH A CONSTITUTIVELY ACTIVE FORM OF THE RETINOBLASTOMA GENE-PRODUCT [J].
CHANG, MW ;
BARR, E ;
SELTZER, J ;
JIANG, YQ ;
NABEL, GJ ;
NABEL, EG ;
PARMACEK, MS ;
LEIDEN, JM .
SCIENCE, 1995, 267 (5197) :518-522